YahooOctober 23, 2026 at 11:33 AM NY4 Days Ago
Merck CEO Plays Down Cost Concerns Over Intismeran — ‘We Don't See Cost As A Limit To Access’
In an interview with CNBC, Merck CEO Rob Davis said the company is confident it can deliver Intismeran at scale.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
